Enhanced Genomics

Enhanced Genomics is a pioneering functional genomics company harnessing its proprietary 3D genomics technology to transform drug target discovery. By integrating 3D genomics with multi-omics approaches, Enhanced leverages 3D Multi-omics to deliver unparalleled insights into gene regulation and disease mechanisms. This innovative approach accelerates the development of novel therapeutics across a wide range of disease areas.

Content by Enhanced Genomics

MRI Brain Scan of head and skull with hand pointing

| 2 min read

byEnhanced Genomics

Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery

Enhanced Genomics’ 3D multi-omics platform harnessed to rapidly identify multiple novel therapeutic targets that were undetectable using conventional genomic approaches

Industry Perspectives

A close-up 3D-rendered illustration of a DNA double helix with a textured surface, set against a dark, blurred background with additional DNA strands.

| 5 min read

byEnhanced Genomics

Revolutionizing drug discovery and precision medicine with 3D multiomics

Researchers gain a deeper understanding of disease mechanisms through integrating 3D multiomics, paving the way for more precise and efficient drug discovery.

Industry Perspectives

Page 1 of 1 - 2 Total Items

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.

Automating the counting of 3D cell cultures

Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.

Webinars

Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.

Imaging neural activity in action

Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.

Infographics

Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.

Building complex in vitro models to support new approach methodologies

As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?